Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis

• Published in: Pharmaceutics 2021-02, Vol.13 (2), p.256
• Main Authors: Lin, Grace C, Küng, Erik, Smajlhodzic, Merima, Domazet, Sandra, Friedl, Heinz P, Angerer, Joachim, Wisgrill, Lukas, Berger, Angelika, Bingle, Lynne, Peham, Johannes R, Neuhaus, Winfried
• Format: Article
• Language: English
• Subjects: immunology; infectious disease; neonatal sepsis; neonatology; saliva diagnostics; TR146
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics13020256

C-reactive protein (CRP) is a commonly used serum biomarker for detecting sepsis in neonates. After the onset of sepsis, serial measurements are necessary to monitor disease progression; therefore, a non-invasive detection method is beneficial for neonatal well-being. While some studies have shown a correlation between serum and salivary CRP levels in septic neonates, the causal link behind this correlation remains unclear. To investigate this relationship, CRP was examined in serum and saliva samples from 18 septic neonates and compared with saliva samples from 22 healthy neonates. While the measured blood and saliva concentrations of the septic neonates varied individually, a correlation of CRP levels between serum and saliva samples was observed over time. To clarify the presence of active transport of CRP across the blood-salivary barrier (BSB), transport studies were performed with CRP using in vitro models of oral mucosa and submandibular salivary gland epithelium. The results showed enhanced transport toward saliva in both models, supporting the clinical relevance for salivary CRP as a biomarker. Furthermore, CRP regulated the expression of the receptor for advanced glycation end products (RAGE) and the addition of soluble RAGE during the transport studies indicated a RAGE-dependent transport process for CRP from blood to saliva.